BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Abacavir

A carbocyclic nucleoside reverse transcriptase inhibitor with potent and selective anti-HIV activity.

295+ PubMed studies analyzed · 42 RCTs · Evidence Score: 50.8

Research Domains

Abacavir has been studied across 12 research domains including ❤️ Cardiovascular, 🛡️ Immunity, 🔬 Inflammation, 🔬 Oncology, 🫁 Liver & Detox. The primary research focus is ❤️ Cardiovascular with 5% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Abacavir, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Lamivudine
4 shared targets
etravirine
3 shared targets
cefuroxime
3 shared targets
Emtricitabine
3 shared targets
Cephradine
3 shared targets
Olmesartan
4 shared targets
mk
2 shared targets
Delavirdine
4 shared targets
Cefoxitin
3 shared targets
Darunavir
3 shared targets
Loading evidence profile...

This evidence profile for Abacavir is generated deterministically from 295 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.